Rankings
▼
Calendar
ZTS Q1 2021 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$54B
Q1 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.9B
+22.0% YoY
Gross Profit
$1.3B
68.5% margin
Operating Income
$755M
40.4% margin
Net Income
$559M
29.9% margin
EPS (Diluted)
$1.17
QoQ Revenue Growth
+3.5%
Cash Flow
Operating Cash Flow
$400M
Free Cash Flow
$323M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$13.8B
Total Liabilities
$9.7B
Stockholders' Equity
$4.1B
Cash & Equivalents
$3.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.9B
$1.5B
+22.0%
Gross Profit
$1.3B
$1.0B
+23.9%
Operating Income
$755M
$539M
+40.1%
Net Income
$559M
$423M
+32.2%
Revenue Segments
Dogs and Cats
$1.0B
55%
Cattle
$399M
22%
Swine
$190M
10%
Poultry
$131M
7%
Horses
$60M
3%
Fish
$37M
2%
Geographic Segments
United States Segment
$933M
50%
International Segment
$922M
50%
← FY 2021
All Quarters
Q2 2021 →